Check Claims Before You Publish

• Luca Giordano is listed among the authors of a comprehensive 2025 review on mitochondrial DNA (mtDNA) signaling and innate immunity; that review includes a funding note explicitly naming a 'Vascular Medicine Institute Postdoctoral Award to Luca Giordano' (Giordano 2025 mtDNA review).
• However, simple author‑level bibliometrics attached to the query indicate a very small footprint (2 papers, 2 citations, h‑index=1) under that exact name — this is compatible with either an early‑career author or incomplete indexing/ambiguity; OpenAlex returns multiple persons named 'Luca Giordano', including at least one profile with much higher productivity (works_count=166, h_index=14), showing strong name ambiguity risk (OpenAlex ).

The 2025 review, where Luca Giordano is named, is a high‑quality synthesis addressing mechanisms by which mislocalized mtDNA activates innate immune receptors (cGAS‑STING, AIM2, NLRP3, TLR9, ZBP1), lists experimental models (cell lines, KO mice, human specimens), highlights therapeutic targets and methodological caveats, and declares no competing interests — this indicates substantive domain knowledge and participation in a substantial scholarly product (Giordano 2025 review details).

• Name disambiguation: multiple 'Luca Giordano' profiles exist; local minimal metrics (2 papers/2 citations/h=1) conflict with OpenAlex higher‑productivity entries — do not conflate records without ORCID/affiliation confirmation (OpenAlex name ambiguity).
• Authorship role ambiguity: the review is multi‑author; being a named author (and recipient of a postdoc award) indicates contribution but does not by itself establish senior PI status or independent primary‑data production — corroborate via CV, ORCID, or contribution statements in the paper (Authorship and funding note).
• Bibliometric incompleteness: small counts may reflect incomplete indexing (books, conference proceedings, non-indexed outputs), name variants, or recent entry into publishing; bibliometrics alone are insufficient to judge scientific merit.

1. Cross‑check ORCID or institutional webpage for the Luca Giordano who is acknowledged with a Vascular Medicine Institute postdoc award in the 2025 paper (to disambiguate records). (Funding mention for Luca Giordano)
2. Ask for CV/ORCID or confirm contribution statement to assess role (lead vs contributor) and presence of primary data publications.
3. If hiring/collaboration is considered, request sample code/data or a short presentation of ongoing primary research for evaluation of experimental rigor and reproducibility.

Evidence confirms a substantive scholarly contribution (a 2025 review in a specialty journal) involving Luca Giordano, supported by an explicit funding note naming him, which indicates active research participation in mitochondrial immunology; however, bibliometric indicators attached directly to the queried name are minimal and OpenAlex shows multiple individuals sharing the name — therefore, the scientifically conservative conclusion is: the person named Luca Giordano in the 2025 review is a legitimate contributor in this domain, but the overall scientific standing (independent productivity and impact) cannot be judged from name alone without identity disambiguation (Giordano 2025 review support OpenAlex ambiguity).